Get started
Author

Nan Ding

Observed names: Ding, Nan, N. Ding
ORCID: 0009-0002-3725-4269
Observed ORCID: 0009-0002-3725-4269
OpenAlex ID: A5074699630
Rapid Internal Control Reference Recombinase-Aided Amplification Assays for EBV and CMV Detection.
2021 · Yuan Gao, Yan Qing Tie, et al. · PubMed · 8
Pyroptosis-Mediator GSDMD in Plasma: A Potent Biomarker Lung Cancer Diagnosis and Prognosis Assessment
2025 · Xuexin Liu, Fang Yu, et al. · International Journal of General Medicine · 5
PDF
Pyroptosis-Mediator GSDMD in Plasma: A Promising Biomarker for Early Diagnosis of Type 2 Diabetes
2025 · Lijing Huo, Xuexin Liu, et al. · Diabetes Metabolic Syndrome and Obesity · 3
PDF
Pyroptosis-mediator Gasdermin D in serum: a potential biomarker in diabetic kidney disease
2026 · Nan Ding, Changmei Wei, et al. · Frontiers in Endocrinology · 2
PDF
The Diagnostic and Progressive Value of Serum GSDMD in Patients with Heart Failure: A Retrospective Study
2025 · Changmei Wei, Nan Ding, et al. · International Journal of General Medicine
PDF
LDLR c.89_92dup: a novel frameshift variation in familial hypercholesterolemia
2024 · Jialing Deng, Ju Zhang, et al. · Lipids in Health and Disease
1011P MET and NF2 alterations confer early resistance to first-line alectinib treatment in ALK-rearranged non-small cell lung cancer
2022 · J. Hu, N. Ding, et al. · Annals of Oncology
Works count: 10
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type